Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1968 Aug 31;3(5617):515–521. doi: 10.1136/bmj.3.5617.515

Chronic Cholangitides: Aetiology, Diagnosis, and Treatment*

Sheila Sherlock
PMCID: PMC1986450  PMID: 4971054

Abstract

A number of different chronic diseases affect the intrahepatic bile radicles or cholangioles. They include primary and secondary sclerosing cholangitis, primary biliary cirrhosis, chronic cholestatic drug jaundice, atresia, and carcinoma. Aetiological factors include infection, immunological changes, hormones, and congenital defects.

Patients with chronic cholestasis have decreased bile salts in the intestinal contents and suffer from a bile salt deficiency syndrome. Failure to absorb dietary fat is managed by a low-fat diet and by medium-chain trigly-cerides which are absorbed in the absence of intestinal bile salts. Fat-soluble vitamin deficiencies are prevented by parenteral vitamins A, D, and K1. Calcium absorption is defective, and improvement may follow intramuscular vitamin D, medium-chain triglycerides, a low-fat diet, and oral calcium supplements.

In partial intestinal bile salt deficiency the anionic bile-salt-chelating resin cholestyramine controls pruritus though steatorrhoea increases. Pruritus associated with total lack of intestinal bile salts is managed by methyl-testosterone or norethandrolone, though the jaundice increases.

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHERSON G. L., BROBERGER O. Incidence of haemagglutinating and complement-fixing antibodies. Br Med J. 1961 May 20;1(5237):1429–1433. doi: 10.1136/bmj.1.5237.1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ATKINSON M., NORDIN B. E., SHERLOCK S. Malabsorption and bone disease in prolonged obstructive jaundice. Q J Med. 1956 Jul;25(99):299–312. [PubMed] [Google Scholar]
  3. BAKER D. H., HARRIS R. C. CONGENITAL ABSENCE OF THE INTRAHEPATIC BILE DUCTS. Am J Roentgenol Radium Ther Nucl Med. 1964 Apr;91:875–884. [PubMed] [Google Scholar]
  4. BOUCHIER I. A., RHODES K., SHERLOCK S. SEROLOGICAL ABNORMALITIES IN PATIENTS WITH LIVER DISEASE. Br Med J. 1964 Mar 7;1(5383):592–594. doi: 10.1136/bmj.1.5383.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berg P. A., Doniach D., Roitt I. M. Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J Exp Med. 1967 Aug 1;126(2):277–290. doi: 10.1084/jem.126.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burke V., Danks D. M. Medium-chain triglyceride diet: its use in treatment of liver disease. Br Med J. 1966 Oct 29;2(5521):1050–1051. doi: 10.1136/bmj.2.5521.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CAREY J. B. BILE ACIDS, CIRRHOSIS, AND HUMAN EVOLUTION. Gastroenterology. 1964 Apr;46:490–493. [PubMed] [Google Scholar]
  8. Carey J. B., Jr, Wilson I. D., Zaki F. G., Hanson R. F. The metabolism of bile acids with special reference to liver injury. Medicine (Baltimore) 1966 Nov;45(6):461–470. doi: 10.1097/00005792-196645060-00009. [DOI] [PubMed] [Google Scholar]
  9. DATTA D. V., SHERLOCK S., SCHEUER P. J. POST-NECROTIC CIRRHOSIS WITH CHRONIC CHOLESTASIS. Gut. 1963 Sep;4:223–230. doi: 10.1136/gut.4.3.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. DEICHER H. R., HOLMAN H. R., KUNKEL H. G. Anti-cytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases. Arthritis Rheum. 1960 Feb;3:1–15. doi: 10.1002/art.1780030102. [DOI] [PubMed] [Google Scholar]
  11. Datta D. V., Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology. 1966 Mar;50(3):323–332. [PubMed] [Google Scholar]
  12. Doniach D., Roitt I. M., Walker J. G., Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PMC free article] [PubMed] [Google Scholar]
  13. Feizi T. Immunoglobulins in chronic liver disease. Gut. 1968 Apr;9(2):193–198. doi: 10.1136/gut.9.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fischer J. A., Schmid M. Treatment of primary biliary cirrhosis with azothioprine. Lancet. 1967 Feb 25;1(7487):421–424. doi: 10.1016/s0140-6736(67)91180-4. [DOI] [PubMed] [Google Scholar]
  15. Goudie R. B., Macsween R. N., Goldberg D. M. Serological and histological diagnosis of primary biliary cirrhosis. J Clin Pathol. 1966 Nov;19(6):527–538. doi: 10.1136/jcp.19.6.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kehayoglou A. K., Holdsworth C. D., Agnew J. E., Whelton M. J., Sherlock S. Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet. 1968 Apr 6;1(7545):715–718. doi: 10.1016/s0140-6736(68)92164-8. [DOI] [PubMed] [Google Scholar]
  17. Kreek M. J., Sleisenger M. H., Jeffries G. H. Recurrent cholestatic jaundice of pregnancy with demonstrated estrogen sensitivity. Am J Med. 1967 Nov;43(5):795–803. doi: 10.1016/0002-9343(67)90122-2. [DOI] [PubMed] [Google Scholar]
  18. Levine R. A., Briggs G. W., Lowell D. M. Chronic chlorpromazine cholangiolitic hepatitis. Report of a case with immunofluorescent studies. Gastroenterology. 1966 May;50(5):665–670. [PubMed] [Google Scholar]
  19. Linscheer W. G., Patterson J. F., Moore E. W., Clermont R. J., Robins S. J., Chalmers T. C. Medium and long chain fat absorption in patients with cirrhosis. J Clin Invest. 1966 Aug;45(8):1317–1325. doi: 10.1172/JCI105438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. MYERS J. D., OLSON R. E., LEWIS J. H., MORAN T. J. Xanthomatous biliary cirrhosis following chlorpromazine, with observations indicating overproduction of cholesterol, hyperprothrombinemia, and the development of portal hypertension. Trans Assoc Am Physicians. 1957;70:243–261. [PubMed] [Google Scholar]
  21. Mendell P. L. Addison's disease and diabetes mellitus. Proc R Soc Med. 1966 Jun;59(6):568–569. [PMC free article] [PubMed] [Google Scholar]
  22. Mistilis S. P., Skyring A. P., Goulston S. J. Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis. Australas Ann Med. 1965 Nov;14(4):286–294. doi: 10.1111/imj.1965.14.4.286. [DOI] [PubMed] [Google Scholar]
  23. Morgan D. B., Paterson C. R., Woods C. G., Pulvertaft C. N., Fourman P. Search for osteomalacia in 1228 patients after gastrectomy and other operations on the stomach. Lancet. 1965 Nov 27;2(7422):1085–1088. doi: 10.1016/s0140-6736(65)90060-7. [DOI] [PubMed] [Google Scholar]
  24. OSBORN E. C., WOOTTON I. D., da SILVA L., SHERLOCK S. Serum-bile-acid levels in liver disease. Lancet. 1959 Dec 12;2(7111):1049–1053. doi: 10.1016/s0140-6736(59)91527-2. [DOI] [PubMed] [Google Scholar]
  25. PARONETTO F., SCHAFFNER F., POPPER H. IMMUNOCYTOCHEMICAL AND SEROLOGIC OBSERVATIONS IN PRIMARY BILIARY CIRRHOSIS. N Engl J Med. 1964 Nov 26;271:1123–1128. doi: 10.1056/NEJM196411262712201. [DOI] [PubMed] [Google Scholar]
  26. Palmer R. H., Ruban Z. Production of bile duct hyperplasia and gallstones by lithocholic acid. J Clin Invest. 1966 Aug;45(8):1255–1267. doi: 10.1172/JCI105432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. READ A. E., HARRISON C. V., SHERLOVK S. Chronic chlorpromazine jaundice: with particular reference to its relationship to primary biliary cirrhosis. Am J Med. 1961 Aug;31:249–258. doi: 10.1016/0002-9343(61)90113-9. [DOI] [PubMed] [Google Scholar]
  28. RUBIN E., SCHAFFNER F., POPPER H. PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS. Am J Pathol. 1965 Mar;46:387–407. [PMC free article] [PubMed] [Google Scholar]
  29. Rankin J. G., Skyring A. P., Goulston S. J. Liver in ulcerative colitis: obstructive jaundice due to bile duct carcinoma. Gut. 1966 Oct;7(5):433–437. doi: 10.1136/gut.7.5.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. SHERLOCK S. Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology. 1959 Nov;37:574–586. [PubMed] [Google Scholar]
  31. STAUFFER M. H., SAUER W. G., DEARING W. H., BAGGENSTOSS A. H. THE SPECTRUM OF CHOLESTATIC HEPATIC DISEASE. JAMA. 1965 Mar 8;191:829–837. doi: 10.1001/jama.1965.03080100047011. [DOI] [PubMed] [Google Scholar]
  32. STOWENS D. CONGENITAL BILIARY ATRESIA. Ann N Y Acad Sci. 1963 Dec 30;111:337–357. doi: 10.1111/j.1749-6632.1963.tb36976.x. [DOI] [PubMed] [Google Scholar]
  33. Scott A. J., Khan G. A. Partial biliary obstruction with cholangitis producing a blind loop syndrome. Gut. 1968 Apr;9(2):187–192. doi: 10.1136/gut.9.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sherlock S. Biliary secretory failure in man. The problem of cholestasis. Ann Intern Med. 1966 Sep;65(3):397–408. doi: 10.7326/0003-4819-65-3-397. [DOI] [PubMed] [Google Scholar]
  35. Smetana H. F., Edlow J. B., Glunz P. R. Neonatal jaundice. A critical review of persistent obstructive jaundice in infancy. Arch Pathol. 1965 Dec;80(6):553–574. [PubMed] [Google Scholar]
  36. Thorpe M. E., Scheuer P. J., Sherlock S. Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut. 1967 Oct;8(5):435–448. doi: 10.1136/gut.8.5.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. WALKER J. G., DONIACH D., ROITT I. M., SHERLOCK S. SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet. 1965 Apr 17;1(7390):827–831. doi: 10.1016/s0140-6736(65)91372-3. [DOI] [PubMed] [Google Scholar]
  38. Walker C. O., Combes B. Biliary cirrhosis induced by chlorpromazine. Gastroenterology. 1966 Nov;51(5):631–640. [PubMed] [Google Scholar]
  39. Webling D. D., Holdsworth E. S. The effect of bile, bile acids and detergents on calcium absorption in the chick. Biochem J. 1965 Nov;97(2):408–421. doi: 10.1042/bj0970408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Zaki F. G., Carey J. B., Jr, Hoffbauer F. W., Nwokolo C. Biliary reaction and choledocholithiasis induced in the rat by lithocholic acid. J Lab Clin Med. 1967 May;69(5):737–748. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES